FDA Panel Votes 17-0 In Favor of Safety, Effectiveness of OraSure's (OSUR) At-Home HIV Test
Tweet
Share
E-mailGet Alerts OSUR Hot Sheet
Join SI Premium – FREE
An FDA Panel has just voted OraSure's (Nasdaq: OSUR) at-home HIV test is safe and effective. The vote was 17-0 in favor.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- CoVolt Power files for proposed IPO
- enVVeno Medical (NVNO) files $100M mixed shelf
Create E-mail Alert Related Categories
Corporate News, FDA, Hot FDA News, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
